A new trading day began on Tuesday, with Opko Health Inc (NASDAQ: OPK) stock price down -4.65% from the previous day of trading, before settling in for the closing price of $1.72. OPK’s price has ranged from $0.86 to $1.76 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 6.34%. Meanwhile, its annual earnings per share averaged 28.00%. With a float of $308.55 million, this company’s outstanding shares have now reached $682.48 million.
Let’s determine the extent of company efficiency that accounts for 3930 employees. In terms of profitability, gross margin is 16.19%, operating margin of -26.43%, and the pretax margin is -16.57%.
Opko Health Inc (OPK) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Opko Health Inc is 54.79%, while institutional ownership is 30.91%. The most recent insider transaction that took place on Jan 28 ’25, was worth 70,060. In this transaction CEO & Chairman of this company bought 47,537 shares at a rate of $1.47, taking the stock ownership to the 213,234,014 shares. Before that another transaction happened on Jan 17 ’25, when Company’s CEO & Chairman bought 150,000 for $1.47, making the entire transaction worth $220,425. This insider now owns 213,186,477 shares in total.
Opko Health Inc (OPK) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 28.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.98% during the next five years compared to 1.56% growth over the previous five years of trading.
Opko Health Inc (NASDAQ: OPK) Trading Performance Indicators
Here are Opko Health Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.69. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.57.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.19, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.29 in one year’s time.
Technical Analysis of Opko Health Inc (OPK)
Looking closely at Opko Health Inc (NASDAQ: OPK), its last 5-days average volume was 2.44 million, which is a drop from its year-to-date volume of 2.77 million. As of the previous 9 days, the stock’s Stochastic %D was 57.14%. Additionally, its Average True Range was 0.06.
During the past 100 days, Opko Health Inc’s (OPK) raw stochastic average was set at 69.23%, which indicates a significant increase from 44.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 37.87% in the past 14 days, which was higher than the 34.47% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5516, while its 200-day Moving Average is $1.4792. However, in the short run, Opko Health Inc’s stock first resistance to watch stands at $1.7033. Second resistance stands at $1.7667. The third major resistance level sits at $1.8033. If the price goes on to break the first support level at $1.6033, it is likely to go to the next support level at $1.5667. Now, if the price goes above the second support level, the third support stands at $1.5033.
Opko Health Inc (NASDAQ: OPK) Key Stats
With a market capitalization of 1.12 billion, the company has a total of 682,483K Shares Outstanding. Currently, annual sales are 863,500 K while annual income is -188,860 K. The company’s previous quarter sales were 173,630 K while its latest quarter income was 24,890 K.
